Arcadia Biosciences, Inc.

NasdaqCM:RKDA Stock Report

Market Cap: US$5.9m

Arcadia Biosciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Thomas Schaefer

Chief executive officer

US$499.5k

Total compensation

CEO salary percentage52.05%
CEO tenureless than a year
CEO ownership0.2%
Management average tenureno data
Board average tenure7yrs

Recent management updates

Recent updates

author-image

Zola Distribution Expansion Will Unlock Enduring Market Strength

Arcadia's focus on expanding Zola distribution and profitable product lines is set to drive revenue growth and improve earnings through high-margin sales.

We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely

Mar 01
We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely

Arcadia Biosciences to raise $5M in securities offering

Aug 15

Arcadia Biosciences: Market Still Unconvinced Of Its Health Offerings

Nov 29

We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit

Nov 22
We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit

CEO Compensation Analysis

How has Thomas Schaefer's remuneration changed compared to Arcadia Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$771k

Dec 31 2024US$499kUS$260k

-US$4m

Sep 30 2024n/an/a

-US$731k

Jun 30 2024n/an/a

-US$190k

Mar 31 2024n/an/a

US$3m

Dec 31 2023US$382kUS$260k

-US$5m

Compensation vs Market: Thomas's total compensation ($USD499.48K) is about average for companies of similar size in the US market ($USD651.56K).

Compensation vs Earnings: Thomas's compensation has increased whilst the company is unprofitable.


CEO

Thomas Schaefer (48 yo)

less than a year
Tenure
US$499,477
Compensation

Mr. Thomas J. Schaefer serves as Chief Executive Officer and President of Arcadia Biosciences, Inc. from July 03, 2024 and is its Director since August 1, 2024. He served as Chief Financial Officer of Arca...


Board Members

NamePositionTenureCompensationOwnership
Thomas Schaefer
CEO, President & Directorless than a yearUS$499.48k0.21%
$ 12.1k
Gregory Waller
Independent Director7.9yrsUS$90.97k0%
$ 0
Lilian Murray
Independent Director6.9yrsUS$92.47k0.016%
$ 915.7
Albert Bolles
Independent Director7yrsUS$72.97k0%
$ 0
Kevin Comcowich
Independent Chair of the Board8.6yrsUS$153.44k0.037%
$ 2.1k
Amy Yoder
Independent Director7.9yrsUS$88.97k0%
$ 0
Deborah Carosella
Independent Director4.3yrsUS$83.47k0%
$ 0
7.0yrs
Average Tenure
65yo
Average Age

Experienced Board: RKDA's board of directors are considered experienced (7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/27 00:26
End of Day Share Price 2025/05/27 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arcadia Biosciences, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Benjamin KlieveLake Street Capital Markets, LLC
Jon RitzenthalerPiper Sandler Companies
Brett William WongPiper Sandler Companies